Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates

Glioblastoma multiforme is the most frequent primary malignancy of the central nervous system. Despite remarkable progress towards an understanding of tumor biology, there is no efficient treatment and patient outcome remains poor. Here, we present a unique anti-proteomic approach for selection of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovčevska, Ivana, Zupanec, Neja, Urlep, Žiga, Vranič, Andrej, Matos, Boštjan, Stokin, Clara Limbaeck, Muyldermans, Serge, Myers, Michael P., Buzdin, Anton A., Petrov, Ivan, Komel, Radovan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546469/
https://www.ncbi.nlm.nih.gov/pubmed/28498803
http://dx.doi.org/10.18632/oncotarget.17390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546469/
https://www.ncbi.nlm.nih.gov/pubmed/28498803
http://dx.doi.org/10.18632/oncotarget.17390

Ejemplares similares